National Cancer Institute cohort

Aliases

NCI

Related entities (2)

Mentioned in (16)

Papers in which this entity is mentioned.

• Efficient and accurate search in petabase-scale sequence repositories. (2025)
• A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns. (2023)
• Inferring gene expression from cell-free DNA fragmentation profiles. (2022)
• Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. (2021)
• Application of third-generation sequencing in cancer research. (2021)
• Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. (2020)
• Predicting T cell recognition of MHC class I restricted neoepitopes. (2018)
• Substantial contribution of extrinsic risk factors to cancer development. (2016)
• Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. (2015)
• Pioneering the Transdisciplinary Team Science Approach: Lessons Learned from National Cancer Institute Grantees. (2014)
• The Genotype-Tissue Expression (GTEx) project. (2013)
• Cognition assessment using the NIH Toolbox. (2013)
• Managing incidental findings and research results in genomic research involving biobanks and archived data sets. (2012)
• Detectable clonal mosaicism from birth to old age and its relationship to cancer. (2012)
• Circulating microRNAs as stable blood-based markers for cancer detection. (2008)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.